Study of RO7515629 in Participants With HLA-G Positive Solid Tumors
Condition: Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer Interventions: Drug: RO7515629; Drug: tocilizumab Sponsor: Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actemra | Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Colorectal Cancer | Kidney Cancer | Lung Cancer | Non-Small Cell Lung Cancer | Pancreas | Pancreatic Cancer | Renal Cell Carcinoma | Research | Study